Just under 17% of 10- to 17-year-olds who started a GLP-1 drug were diagnosed with a nutritional deficiency or a related complication within the following year, an analysis of US insurance claims has found. Most of those diagnoses were vitamin D deficiency. Fewer than a quarter of the teenagers saw anyone for nutrition counselling within … Read more
A dual GLP-1/GIP receptor agonist made by a Chinese biotech produced up to 18.3% weight loss over 24 weeks in a placebo-controlled phase 2 trial, according to results published on 17 September in Diabetes, Obesity and Metabolism. The drug, BGM0504, acts on the same two gut-hormone receptors as tirzepatide. The trial was small, at 120 … Read more
If you take a GLP-1 drug and have an operation booked, this is the study to know about. Across 119 UK hospitals and 47,039 patients, regurgitation or stomach contents entering the lungs happened to about 1 in 71 people taking a GLP-1 drug, against about 1 in 802 of everyone else. The events clustered at … Read more
Adolescents with obesity who started semaglutide, liraglutide or tirzepatide were less likely to have a recorded suicide-related event over up to three years than matched adolescents managed with lifestyle intervention, according to an electronic health records study published on 14 September in Diabetes, Obesity and Metabolism. It points away from psychiatric harm in the age … Read more
The FDA on 15 September 2026 told consumers not to buy or use two products sold for weight loss, LUZE Fit Intensity and Beauty 911, after its laboratory found sibutramine in both. Neither label lists it. Sibutramine was the active ingredient in Meridia, a prescription weight-loss drug whose approval the FDA withdrew in 2010 after … Read more
Nine people reported fever, chills, chest pain or vomiting after receiving compounded injections that a Houston pharmacy has now recalled nationwide. Centric Compounding is pulling six lots of glutathione, Myer’s Cocktail and Tri-Immune Boost, injectables sold to support immunity, fatigue and general wellness, after the glutathione raw ingredient used to make them was found to … Read more
A weight-loss supplement sold directly to consumers online has been recalled nationwide after FDA laboratory testing found two undeclared drugs inside the same box. The daytime tablets of Lipofit Extreme Fat Burner 2.0 contained fluoxetine, a prescription antidepressant. The nighttime tablets contained 2,4-dinitrophenol, a substance the FDA describes as a pesticide, dye, wood preservative and … Read more
Between January 2021 and December 2025, Europe’s pharmacovigilance database logged 42,941 adverse-event reports naming liraglutide, semaglutide or tirzepatide as a suspect drug in diabetes or weight management. Of those, 225 involved suicide or self-injury: 141 for semaglutide, 47 for tirzepatide, 37 for liraglutide. A new analysis sets the three against each other and finds such … Read more